James C. Mullen, CEO & President at BIOGEN IDEC INC. (BIIB), sold 147,037 shares at $50.18 ($7.4M) on 2009-12-16, disclosed to the SEC on 2009-12-18.
Scheduled sale ($7.4M) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EDIT | BUY | 2021-03-04 | $1.2M | — | Filing → |
| EDIT | BUY | 2018-05-22 | $380K | — | Filing → |
| PODD | BUY | 2017-11-14 | $169K | — | Filing → |